Recruitment Ended

Glenn Hearson

APEX Study to better understand asthma attacks has fully recruited

Senior research nurse Karen Shaw with research fellows Rob Needham and Dr Ashish Pradhan have recruited the last required patient into...

Glenn Hearson

Registry of Asthma Patients Initiating DUPIXENT® (RAPID)

We have recently commenced a new observational study to characterize the patients who initiate treatment for asthma with DUPIXENT® in a...

Glenn Hearson

The WAYFINDER study: To assess the efficacy and safety of tezepelumab in Adults With Severe Asthma

We have recently commenced a new severe asthma study sponsored by AstraZeneca which is being led at Nottingham University Hospitals by Dr...

Glenn Hearson

Impact of ELX/TEZ/IVA on Patients With Cystic Fibrosis (TRAJECTORY)

We have recently commenced a new study in conjunction with with Vertex Pharmaceuticals Incorporated and Cardiff and Vale University...

Glenn Hearson

APEX-3; to improve our understanding of what is happening during suspected asthma attacks

We will shortly commence recruitment for our 3rd asthma attack study as part of our APEX research. This 3rd APEX study, will be...

Glenn Hearson

To better understand asthma attacks; The APEX Study

We have been busy working on this new research study into asthma attacks (exacerbations), over the past 30 months and still need more...

Glenn Hearson

A potential new medicine for severe asthma the #SWIFT-1 Study

We will shortly be commencing recruitment into a new asthma trial sponsored by GlaxoSmithKline (GSK) called SWIFT-1 A 52-week,...

Glenn Hearson

Dynamic Assessment of Multi Organ level dysfunction in patients recovering from Covid-19 (DYNAMO)

We have now completed this important #Covid-19 research study and are busy analysing the results. We hope to publish the findings...

1/3